MML Investors Services
PCVX icon

MML Investors Services’s Vaxcyte PCVX Stock Holding History

MML Investors Services’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$323K Buy
+5,559
New +$302K ﹤0.01% 2769
2024
Q4 		– Sell
-2,274
Closed -$260K – 2714
2024
Q3 		$260K Buy
+2,274
New +$205K ﹤0.01% 2274
2023
Q1 		– Sell
-5,211
Closed -$250K – 2205
2022
Q4 		$250K Buy
+5,211
New +$204K ﹤0.01% 1895

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

MML Investors Services's PCVX Position: Q2 2026 in Review

MML Investors Services opened a new position in Vaxcyte (PCVX) in Q2 2026: 5,559 shares worth $323K. The stake represents ﹤0.01% of the portfolio and ranks #2769 among its holdings. This is a return to the name: MML Investors Services previously reported a position in PCVX as recently as Q3 2024.

MML Investors Services first reported a position in PCVX in Q4 2022 and has held it in 3 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • MML Investors Services held 5,559 shares of Vaxcyte worth $323K as of Q2 2026.
  • Vaxcyte was a new MML Investors Services position in Q2 2026.
  • Vaxcyte made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2769 holding.
  • MML Investors Services first reported a position in Vaxcyte in Q4 2022 and has held it in 3 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.